PMID- 20098297 OWN - NLM STAT- MEDLINE DCOM- 20100727 LR - 20201106 IS - 1533-0311 (Electronic) IS - 0193-1091 (Linking) VI - 32 IP - 3 DP - 2010 May TI - p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors. PG - 257-261 LID - 10.1097/DAD.0b013e3181b7fc76 [doi] AB - Cutaneous sclerosing epithelial neoplasms are often difficult to diagnose. Though various immunohistochemical markers have proved useful, some cases remain a diagnostic challenge. We aimed to assess the utility of p63 immunohistochemical staining in distinguishing microcystic adnexal carcinoma (MAC) from sclerosing basal cell carcinoma (SBCC) and desmoplastic trichoepithelioma (DTE). Biopsy samples from 20 SBCC, 10 DTE, and 5 MAC were examined after immunohistochemical staining with p63. Although all adnexal tumors examined demonstrated p63 expression, the pattern of staining was strikingly different in MAC when compared with other tumor types. MAC exhibited a scattered pattern with p63-positive cells around the periphery of tumor nests and minimal staining within the center of the tumor islands. This pattern was more pronounced at increased depth of infiltration into the dermis. A robust and consistent diffuse pattern of staining with p63 was observed in all SBCCs and DTEs. We believe this pattern reflects the multi-differentiation pathway of MAC, with eccrine/sebaceous differentiation occurring at deeper levels of the dermis. The different staining patterns of MACs compared with DTEs and SBCCs can thus serve asa useful diagnostic adjunct in difficult lesions. FAU - Vidal, Claudia I AU - Vidal CI AD - From the *Division of Dermatopathology; daggerDepartments of Pathology; and double daggerOncologic Sciences, Mount Sinai Medical Center, NY. FAU - Goldberg, Matthew AU - Goldberg M FAU - Burstein, David E AU - Burstein DE FAU - Emanuel, Henry J AU - Emanuel HJ FAU - Emanuel, Patrick O AU - Emanuel PO LA - eng PT - Journal Article PL - United States TA - Am J Dermatopathol JT - The American Journal of dermatopathology JID - 7911005 RN - 0 (Biomarkers, Tumor) RN - 0 (TP63 protein, human) RN - 0 (Trans-Activators) RN - 0 (Transcription Factors) RN - 0 (Tumor Suppressor Proteins) SB - IM MH - Biomarkers, Tumor/*analysis MH - Carcinoma, Basal Cell/chemistry/*diagnosis MH - Carcinoma, Skin Appendage/chemistry/*diagnosis MH - Humans MH - Immunoenzyme Techniques MH - Retrospective Studies MH - Skin Neoplasms/chemistry/*diagnosis MH - Trans-Activators/*analysis MH - Transcription Factors MH - Tumor Suppressor Proteins/*analysis EDAT- 2010/01/26 06:00 MHDA- 2010/07/28 06:00 CRDT- 2010/01/26 06:00 PHST- 2010/01/26 06:00 [entrez] PHST- 2010/01/26 06:00 [pubmed] PHST- 2010/07/28 06:00 [medline] AID - 10.1097/DAD.0b013e3181b7fc76 [doi] PST - ppublish SO - Am J Dermatopathol. 2010 May;32(3):257-261. doi: 10.1097/DAD.0b013e3181b7fc76.